Trinity Partners Announces Promotion of Two Veteran West Coast Team Members

Trinity Partners is proud to officially announce the promotion of Krista Perry and John Greenaway to the role of Principal and to Trinity Partners’ Leadership Team. In their new roles, Krista and John will co-lead Trinity Partners’ San Francisco office and consulting team. They will also partner with other Leadership Team members to drive business development and deliver projects to assist west coast biopharmaceutical clients in optimizing their strategic business decisions, commercial planning, and analytics. Further, both Krista and John continue to support the development and training of managers and junior staff.

A graduate of Dartmouth College, Krista Perry joined Trinity Partners in 2006 and has been serving clients as a project manager since 2013. Krista works in the general strategy consulting group and focuses on commercial assessments, prioritizations and launch planning. She has a focus on commercial support for clients focusing on rare diseases, including significant experience working with Trinity’s primary market research group to conduct qualitative and quantitative global research studies with physicians, patients, advocacy groups, payers and other stakeholders in orphan markets.

In addition to her vast experience in rare disease, Krista has broad experience in women’s health. Last year, she led a pro-bono project for the Bill and Melinda Gates Foundation, helping them assess the potential of a collection of maternal vaccines. Krista has been with Trinity Partners for 11 years.

John Greenaway, a graduate of the University of Michigan and Northwestern University’s Kellogg School of Management, joined Trinity Partners in 2010. As part of the strategy consulting team, John supports the consulting and advisory needs for key pharmaceutical and medical device clients and their commercial executives. John provides senior pharmaceutical executives with analytics-based strategic recommendations in forecasting, market opportunity assessments, licensing and acquisition, and product launch planning.

John co-leads for Trinity’s Pricing, Access, Reimbursement, and Contracting (PARC) service, supporting pharmaceutical companies developing market access strategies and implementing pricing, contracting, and patient support programs. In this role, John has spoken and been a panel moderator at several industry conferences. Notably, John has presented Trinity’s published papers “Innovative Contracting Solutions in a Changing Healthcare Landscape” and “Changes to Medical Benefit Reimbursement and Implications for Drug Contracting and Pricing.” Additionally, he has moderated industry panels on “Best Practices to Develop and Implement Effective Pricing and Contracting Strategies.”

“Krista and John are leaders in the Trinity community, contributing to some of the most critical projects in the Strategy Consulting group,” said Dave Fitzhenry, Managing Partner at Trinity Partners. “Both principals truly deserve this recognition, as they are not only experts in what they do, but also genuine team players. As Trinity continues to grow, we are looking forward to seeing how Krista and John evolve in their new roles.”

About Trinity Partners
Trinity Partners is a trusted life sciences strategy consulting firm that takes a personalized approach to working with pharmaceutical, biotech, medical device, and diagnostic clients worldwide to create evidence-based solutions that drive business strategy and impact bottom lines. To learn more about our Partners, click here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s